Blueprint Medicines Corp Collaboration Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Collaboration and License Agreement, dated as of July 27, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Amendment No. 1 to Collaboration and License Agreement, dated as of June 5, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Tenth Amendment to Collaboration and License Agreement, effective August 4, 2016, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2022
Collaboration and License Agreement dated as of February 26, 2022 by and between Oncopia Therapeutics, Inc., d/b/a Proteovant Therapeutics, Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
NY
2022
Ninth Amendment to Collaboration and License Agreement, effective January 8, 2021, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2021
Eighth Amendment to Collaboration and License Agreement, effective April 30, 2020, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2020
Seventh Amendment to Collaboration and License Agreement, effective December 17, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Sixth Amendment to Collaboration and License Agreement, effective November 1, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fifth Amendment to Collaboration and License Agreement, effective June 28, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2016